MapLight officer Gillis proposes $108K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. officer Jonathan Gillis reported a proposed sale of 4,000 voting common shares, with an aggregate market value of $108,080, solely to satisfy tax-withholding obligations tied to restricted stock unit vesting. He acquired 7,305 shares through a restricted stock unit settlement on April 15, 2026. The notice lists 42,436,326 shares outstanding and gives an approximate sale date of April 15, 2026.
Key Figures
Key Terms
restricted stock unit settlement financial
tax-withholding obligations financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.